The Joint Corp. Reports Fourth Quarter and Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
The Joint Corp (JYNT) PT Raised to $15 at DA Davidson Following 4Q
March 8, 2019 8:52 AM ESTDA Davidson analyst Michael Kawamoto raised the price target on The Joint Corp (NASDAQ: JYNT) to $15.00 (from $10.00) while maintaining a Buy rating following the company's 4Q. JYNT reported 4Q18 revenue, EBITDA, and EPS of $9.1M, $1.5M, and $0.06, compared to consensus of $8.6M, $1.2M, and $0.03.... More
The Joint Corp. (JYNT) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 Outlook
March 7, 2019 4:31 PM ESTThe Joint Corp. (NASDAQ: JYNT) reported Q4 EPS of $0.06, $0.03 better than the analyst estimate of $0.03. Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.6 million.
Building upon the foundation we laid out over the past two years, we will continue to accelerate franchise sales, further leverage our regional developer (RD) strategy, and step up the expansion of our corporate clinic portfolio... More
